CIK: 0002010850 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $326,315 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 5,458,810 | $172,335 | 52.8% | $40.84 | -15.1% | COM | 156944100 |
| NUVB | Nuvation Bio Inc. | 6,950,239 | $20,295 | 6.2% | $3.05 | 0.0% | COM | 67080N101 |
| RCUS | Arcus Biosciences, Inc | 869,790 | $13,247 | 4.1% | $15.98 | +1.0% | COM | 03969F109 |
| ZNTL | Zentalis Pharmaceuticals Inc. | 3,070,442 | $12,558 | 3.8% | $13.51 | -17.3% | COM | 98943L107 |
| KRYS | KRYSTAL BIOTECH INC | 65,772 | $12,078 | 3.7% | $110.89 | +51.4% | COM | 501147102 |
| BYSI | BeyondSpring Inc. | 4,958,143 | $11,900 | 3.6% | $0.92 | +170.3% | SHS | G10830100 |
| ILMN | Illumnia, Inc. | 108,767 | $11,353 | 3.5% | $122.34 | -8.3% | COM | 452327109 |
| — | MERUS NV | 179,098 | $10,597 | 3.2% | $51.13 | — | COM | N5749R100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 850,000 | $8,755 | 2.7% | $8.62 | +19.5% | COM | 71722W107 |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 400,000 | $7,684 | 2.4% | $20.06 | 0.0% | COM | N62509109 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 166,600 | $7,325 | 2.2% | $50.23 | — | COM | G4444C102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 347,835 | $7,301 | 2.2% | $25.51 | -1.7% | COM | 35104E100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 157,958 | $7,075 | 2.2% | $39.13 | +18.0% | COM | 22663K107 |
| CYTK | CYTOKINETICS INC | 94,043 | $5,095 | 1.6% | $77.34 | -22.0% | COM | 23282W605 |
| LEGN | LEGEND BIOTECH CORP-ADR | 98,558 | $4,365 | 1.3% | $54.63 | — | ADR | 52490G102 |
| AURA | Aura Biosciences, Inc. | 515,555 | $3,898 | 1.2% | $8.47 | -13.5% | COM | 05153U107 |
| EQ | Equillium Inc. | 4,447,308 | $3,083 | 0.9% | $0.59 | +140.2% | COM | 29446K106 |
| WGS | GeneDx Holdings Corp. | 103,604 | $2,708 | 0.8% | $2.33 | +715.0% | COM CL A | 81663L200 |
| VERA | VERA THERAPEUTICS INC | 69,767 | $2,524 | 0.8% | $39.67 | 0.0% | COM | 92337R101 |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | $1,082 | 0.3% | $1.71 | +145.5% | COM | 747324101 |
| ATRC | AtriCure Inc. | 26,797 | $610 | 0.2% | $37.19 | -37.9% | COM | 04963C209 |
| GRAL | GRAIL INC | 18,127 | $279 | 0.1% | $16.22 | 0.0% | COM | 384747101 |
| — | Nuvation Bio Inc. | 646,057 | $103 | 0.0% | $0.16 | — | WARRANTS | 67080N119 |
| ACLX | ARCELLX INC | 1,177 | $65 | 0.0% | $54.36 | 0.0% | COM | 03940C100 |